Genmab — November 2016
-
Hej alle...Kan sagtens bruge flere spørgsmål til Q&A. Byd endelig ind. Vi skal lave den skarpeste Q&A nogensinde med Jan van de Winkel.
-
Kan godt bruge nogle spørgsmål på teknologiplatformene.
-
Nu lavede Nordea stuntet igen igen og væltede aktier ud i slutauktionen. Anonyme tog en pæn del af dem.
-
therapy of daratumumab in combination with cyclophosphamide, bortezomib, and dexamethasone (Dara-CyBorD), in previously untreated subjects, and in relapsed subjects with multiple myeloma, as defined by the International Myeloma Working Group (IMWG) criteria.https://clinicaltrials.gov/ct2/show/NCT02951819?term=daratumumab&rank=29
-
Er der nogle af jer, der har en holdning til eller kender til dette cancermiddel Ninlaro, der er i konkurrence med Darzalex? Det er i følge firmaet Takedas stort. Se medwatch.dk - artikel fra i dag http://medwatc
h.dk/Medicinal___Biotek/article9116127.ece
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind